Literature DB >> 21732154

Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis.

S Ebert1, K-P Schweiger, R Nau.   

Abstract

An 85-year-old man with myasthenia gravis was successfully treated with methotrexate (10 mg/week), pyridostigmine and prednisolone (0-30 mg/day) for over 10 years. Then, he developed dysphagia and lost weight. Gastroscopy revealed Candida esophagitis. The patient received nystatin for 2 weeks. Methotrexate was stopped, and immunosuppressive therapy was continued with prednisolone alone. The patient has now remained in good condition for over 1 year. Although dysphagia is a typical symptom of myasthenia gravis, swallowing disturbances should not be attributed hastily to this disease, since they may also be a complication of therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732154     DOI: 10.1007/s00391-011-0213-2

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  9 in total

Review 1.  The incidence of myasthenia gravis: a systematic literature review.

Authors:  Anita McGrogan; Samantha Sneddon; Corinne S de Vries
Journal:  Neuroepidemiology       Date:  2010-02-02       Impact factor: 3.282

Review 2.  Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.

Authors:  J A Vazquez
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

3.  Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature.

Authors:  J R Mackey; S Desai; L Larratt; V Cwik; J M Nabholtz
Journal:  Bone Marrow Transplant       Date:  1997-05       Impact factor: 5.483

4.  Myasthenia gravis in the elderly: Is it different?

Authors:  Johan A Aarli
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

5.  An unusual primary presentation of myasthenia gravis.

Authors:  Richard J Cook; Helen McParland; Michael Escudier
Journal:  Br J Oral Maxillofac Surg       Date:  2008-03-04       Impact factor: 1.651

6.  Swallowing problems in neuromuscular disorders.

Authors:  T N Willig; J Paulus; J Lacau Saint Guily; C Béon; J Navarro
Journal:  Arch Phys Med Rehabil       Date:  1994-11       Impact factor: 3.966

7.  Incidence and treatment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective randomized trial of cyclosporine versus antilymphocyte globulin-azathioprine.

Authors:  T Frick; D S Fryd; R L Goodale; R L Simmons; D E Sutherland; J S Najarian
Journal:  Am J Surg       Date:  1988-02       Impact factor: 2.565

8.  Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols.

Authors:  K L Gupta; A K Ghosh; R Kochhar; V Jha; A Chakrabarti; V Sakhuja
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

9.  Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.

Authors:  J B Andersen; A Engeland; J F Owe; N E Gilhus
Journal:  Eur J Neurol       Date:  2010-12       Impact factor: 6.089

  9 in total
  1 in total

1.  Morphological and Molecular Characterization of Exophiala polymorpha sp. nov. Isolated from Sporotrichoid Lymphocutaneous Lesions in a Patient with Myasthenia Gravis.

Authors:  Lee K Yong; Nathan P Wiederhold; Deanna A Sutton; Marcelo Sandoval-Denis; Jonathan R Lindner; Hongxin Fan; Carmita Sanders; Josep Guarro
Journal:  J Clin Microbiol       Date:  2015-06-17       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.